SCA
REGN icon

Stonebridge Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Stonebridge Capital Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17
Closed -$14K – 703
2023
Q3 		$14K Hold
17
– – ﹤0.01% 550
2023
Q2 		$12.2K Hold
17
– – ﹤0.01% 587
2023
Q1 		$14K Buy
17
+5
+42% +$3.77K ﹤0.01% 562
2022
Q4 		$8.66K Buy
12
+2
+20% +$1.48K ﹤0.01% 621
2022
Q3 		$7K Hold
10
– – ﹤0.01% 644
2022
Q2 		$6K Hold
10
– – ﹤0.01% 693
2022
Q1 		$7K Sell
10
-2
-17% -$1.26K ﹤0.01% 729
2021
Q4 		$8K Hold
12
– – ﹤0.01% 679
2021
Q3 		$7K Sell
12
-3
-20% -$1.86K ﹤0.01% 679
2021
Q2 		$8K Buy
15
+10
+200% +$5.07K ﹤0.01% 775
2021
Q1 		$2K Buy
+5
New +$2.43K ﹤0.01% 854

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return